Key insights
- The author expresses a bullish outlook on GLP-1 drugs, noting personal positive experiences and potential shifts in consumer behavior away from alcohol and unhealthy food. While acknowledging major players like LLY and NVO, the author questions their long-term dominance due to potential competition from generics and third-party suppliers. The article also draws a parallel to Victoria's Secret's recent performance, suggesting a link to increased consumer confidence in body image, and seeks similar investment ideas.
Keeping a long story short I recently got on GLPs for alcoholism and it worked almost immediately (I am not overweight)
Within a few weeks my bloodwork retest showed massive gains. I’m eating drastically healthier, and exercising and sleeping better.
I’m quite bearish on alcohol and certain fast food chains as the population becomes more and more accepting of these drugs.
Obviously LLY or NVO are decent options, but it isn’t even clear if these guys will be the winners as so many people are finding cheaper 3rd parties, generics, etc to get their doses from.
Victorias Secret popped off recently given how confident many Americans are stating to get with their bodies.
What other stocks might be connected in a way similar to VSXY?